Femara (Fe-MAR-a, letrozole), a new hormonal therapy for advanced breast cancer

Novartis will soon launch Femara (Fe-MAR-a, letrozole), a new hormonal therapy for advanced breast cancer. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote